The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1237
ISSUE1237
June 19, 2006
Conivaptan (Vaprisol) for Hyponatremia
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Conivaptan (Vaprisol) for Hyponatremia
June 19, 2006 (Issue: 1237)
Conivaptan hydrochloride (Vaprisol - Astellas), a vasopressin antagonist, has been approved by the FDA for short-term intravenous (IV) treatment of euvolemic hyponatremia in hospitalized patients. Euvolemic hyponatremia is most often caused by the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.